Financials Raily Aesthetic Medicine International Holdings Limited
Equities
2135
KYG7356A1215
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.14 HKD | -7.89% | -15.66% | -70.83% |
04-19 | Raily Aesthetic Medicine International Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-07 | Raily Aesthetic Medicine Forecasts Wider Loss in 2023 | MT |
Valuation
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Capitalization 1 | 648.6 | 502.1 | 289.7 | 182.3 |
Enterprise Value (EV) 1 | 515.4 | 444.7 | 247.7 | 194.3 |
P/E ratio | 127 x | -28.3 x | -18.2 x | -5.61 x |
Yield | - | - | - | - |
Capitalization / Revenue | 3.94 x | 2.67 x | 1.76 x | 0.96 x |
EV / Revenue | 3.13 x | 2.36 x | 1.51 x | 1.03 x |
EV / EBITDA | 14.9 x | -39.5 x | -35.1 x | -30.1 x |
EV / FCF | 17 x | 21.7 x | -9.03 x | -14.9 x |
FCF Yield | 5.87% | 4.61% | -11.1% | -6.7% |
Price to Book | 3.49 x | 2.82 x | 1.74 x | 1.32 x |
Nbr of stocks (in thousands) | 411,000 | 417,808 | 417,808 | 417,808 |
Reference price 2 | 1.578 | 1.202 | 0.6933 | 0.4363 |
Announcement Date | 16/04/21 | 14/04/22 | 21/04/23 | 19/04/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 158.9 | 191.2 | 164.5 | 188.4 | 164.5 | 189.4 |
EBITDA 1 | 34.25 | 23.25 | 34.48 | -11.26 | -7.053 | -6.459 |
EBIT 1 | 29.34 | 17.46 | 27.07 | -19.24 | -20.39 | -22.49 |
Operating Margin | 18.46% | 9.13% | 16.45% | -10.21% | -12.39% | -11.88% |
Earnings before Tax (EBT) 1 | 26.38 | 16.39 | 11.57 | -22.95 | -22.1 | -35.01 |
Net income 1 | 17.86 | 9.897 | 4.251 | -17.69 | -15.91 | -32.46 |
Net margin | 11.23% | 5.18% | 2.58% | -9.39% | -9.67% | -17.14% |
EPS 2 | 0.0521 | 0.0289 | 0.0124 | -0.0425 | -0.0381 | -0.0777 |
Free Cash Flow 1 | 31.37 | -26.23 | 30.26 | 20.49 | -27.44 | -13.02 |
FCF margin | 19.74% | -13.72% | 18.39% | 10.88% | -16.68% | -6.87% |
FCF Conversion (EBITDA) | 91.6% | - | 87.76% | - | - | - |
FCF Conversion (Net income) | 175.7% | - | 711.9% | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 15/12/20 | 15/12/20 | 16/04/21 | 14/04/22 | 21/04/23 | 19/04/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 8.22 | - | - | - | - | 12 |
Net Cash position 1 | - | 20.5 | 133 | 57.4 | 42 | - |
Leverage (Debt/EBITDA) | 0.2401 x | - | - | - | - | -1.714 x |
Free Cash Flow 1 | 31.4 | -26.2 | 30.3 | 20.5 | -27.4 | 2.87 |
ROE (net income / shareholders' equity) | 120% | 19% | 3.51% | -9.9% | -11.6% | -25.3% |
ROA (Net income/ Total Assets) | 18.3% | 7.25% | 7.43% | -3.9% | -3.94% | -4.88% |
Assets 1 | 97.35 | 136.5 | 57.23 | 453.9 | 404.2 | 665.2 |
Book Value Per Share 2 | 0.0400 | 0.2700 | 0.4500 | 0.4300 | 0.4000 | 0.3300 |
Cash Flow per Share 2 | 0.0600 | 0.1400 | 0.3900 | 0.2900 | 0.1900 | 0.1000 |
Capex 1 | 12.7 | 10.8 | 8.34 | 15.8 | 18.9 | 18 |
Capex / Sales | 8.01% | 5.67% | 5.07% | 8.37% | 11.46% | 9.5% |
Announcement Date | 15/12/20 | 15/12/20 | 16/04/21 | 14/04/22 | 21/04/23 | 19/04/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-70.83% | 9.96M | |
-20.16% | 16.21B | |
+4.50% | 12.44B | |
+3.98% | 11.58B | |
+9.72% | 10.79B | |
-2.19% | 7.68B | |
+18.43% | 7.2B | |
+4.49% | 6.67B | |
+50.89% | 4.66B | |
-5.12% | 4.25B |
- Stock Market
- Equities
- 2135 Stock
- Financials Raily Aesthetic Medicine International Holdings Limited